NAOMI DIXON: Open Payments
NPI 1760707251 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 18 payments from 11 companies in 2025. Trend: 2023 $465 · 2024 $912 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $105 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Dexcom, Inc. | 2 | $36 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: BOTOX, AIRSUPRA, Dexcom G6 Transmitter, FARXIGA, UPTRAVI, CARDIOMEMS, VIBERZI, QULIPTA.
Industry payments across AR — which companies pay providers there.
